Harvard Bioscience approves 2023 cash incentive plan for CEO and Interim CFO

HARVARD BIOSCIENCE INC

Compensation Committee approved 2023 annual cash incentive plan on March 6, 2023.
CEO and Interim CFO receive target award as a percentage of 2023 base salary.
Payout can range from 0% to 150% of target based on corporate financial objectives.
No specific targets, dollar amounts, or performance thresholds disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.